nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ERBB2—exocrine gland—pancreatitis	0.0268	0.183	CbGeAlD
Afatinib—ERBB2—gall bladder—pancreatitis	0.0225	0.154	CbGeAlD
Afatinib—BLK—blood—pancreatitis	0.0123	0.0843	CbGeAlD
Afatinib—IRAK1—islet of Langerhans—pancreatitis	0.011	0.0756	CbGeAlD
Afatinib—ERBB2—pancreas—pancreatitis	0.0104	0.071	CbGeAlD
Afatinib—ERBB2—digestive system—pancreatitis	0.00886	0.0606	CbGeAlD
Afatinib—ERBB2—blood—pancreatitis	0.00844	0.0578	CbGeAlD
Afatinib—IRAK1—pancreas—pancreatitis	0.00776	0.0531	CbGeAlD
Afatinib—Keratitis—Hyoscyamine—pancreatitis	0.00686	0.109	CcSEcCtD
Afatinib—IRAK1—blood—pancreatitis	0.00632	0.0432	CbGeAlD
Afatinib—ABL1—islet of Langerhans—pancreatitis	0.00619	0.0423	CbGeAlD
Afatinib—LCK—blood—pancreatitis	0.00616	0.0421	CbGeAlD
Afatinib—ABL1—pancreas—pancreatitis	0.00435	0.0298	CbGeAlD
Afatinib—Dry eye—Hyoscyamine—pancreatitis	0.00411	0.0651	CcSEcCtD
Afatinib—ABL1—digestive system—pancreatitis	0.00371	0.0254	CbGeAlD
Afatinib—ABL1—blood—pancreatitis	0.00354	0.0242	CbGeAlD
Afatinib—Dehydration—Hyoscyamine—pancreatitis	0.003	0.0476	CcSEcCtD
Afatinib—Dry skin—Hyoscyamine—pancreatitis	0.00296	0.0469	CcSEcCtD
Afatinib—Hypokalaemia—Hyoscyamine—pancreatitis	0.00294	0.0466	CcSEcCtD
Afatinib—Insomnia—Propantheline—pancreatitis	0.0028	0.0444	CcSEcCtD
Afatinib—Constipation—Propantheline—pancreatitis	0.00265	0.042	CcSEcCtD
Afatinib—Conjunctivitis—Hyoscyamine—pancreatitis	0.00242	0.0383	CcSEcCtD
Afatinib—ABCG2—blood—pancreatitis	0.00223	0.0153	CbGeAlD
Afatinib—Asthenia—Propantheline—pancreatitis	0.00222	0.0352	CcSEcCtD
Afatinib—Dizziness—Propantheline—pancreatitis	0.00205	0.0325	CcSEcCtD
Afatinib—Vomiting—Propantheline—pancreatitis	0.00197	0.0312	CcSEcCtD
Afatinib—Mental disorder—Hyoscyamine—pancreatitis	0.00196	0.031	CcSEcCtD
Afatinib—Rash—Propantheline—pancreatitis	0.00195	0.031	CcSEcCtD
Afatinib—Dermatitis—Propantheline—pancreatitis	0.00195	0.0309	CcSEcCtD
Afatinib—Headache—Propantheline—pancreatitis	0.00194	0.0308	CcSEcCtD
Afatinib—ABCB1—islet of Langerhans—pancreatitis	0.00192	0.0132	CbGeAlD
Afatinib—Dysgeusia—Hyoscyamine—pancreatitis	0.0019	0.0302	CcSEcCtD
Afatinib—Nausea—Propantheline—pancreatitis	0.00184	0.0292	CcSEcCtD
Afatinib—Insomnia—Hyoscyamine—pancreatitis	0.00144	0.0227	CcSEcCtD
Afatinib—Dyspnoea—Hyoscyamine—pancreatitis	0.00141	0.0224	CcSEcCtD
Afatinib—Dyspepsia—Hyoscyamine—pancreatitis	0.0014	0.0221	CcSEcCtD
Afatinib—Fatigue—Hyoscyamine—pancreatitis	0.00137	0.0217	CcSEcCtD
Afatinib—Constipation—Hyoscyamine—pancreatitis	0.00136	0.0215	CcSEcCtD
Afatinib—ABCB1—pancreas—pancreatitis	0.00135	0.00925	CbGeAlD
Afatinib—Body temperature increased—Hyoscyamine—pancreatitis	0.00125	0.0199	CcSEcCtD
Afatinib—Vandetanib—ALB—pancreatitis	0.00122	0.513	CrCbGaD
Afatinib—Gefitinib—ALB—pancreatitis	0.00116	0.487	CrCbGaD
Afatinib—ABCB1—digestive system—pancreatitis	0.00115	0.0079	CbGeAlD
Afatinib—Asthenia—Hyoscyamine—pancreatitis	0.00114	0.018	CcSEcCtD
Afatinib—Pruritus—Hyoscyamine—pancreatitis	0.00112	0.0178	CcSEcCtD
Afatinib—ABCB1—blood—pancreatitis	0.0011	0.00753	CbGeAlD
Afatinib—Diarrhoea—Hyoscyamine—pancreatitis	0.00109	0.0172	CcSEcCtD
Afatinib—Dizziness—Hyoscyamine—pancreatitis	0.00105	0.0166	CcSEcCtD
Afatinib—Vomiting—Hyoscyamine—pancreatitis	0.00101	0.016	CcSEcCtD
Afatinib—Rash—Hyoscyamine—pancreatitis	0.001	0.0159	CcSEcCtD
Afatinib—Dermatitis—Hyoscyamine—pancreatitis	0.001	0.0158	CcSEcCtD
Afatinib—Headache—Hyoscyamine—pancreatitis	0.000994	0.0158	CcSEcCtD
Afatinib—Nausea—Hyoscyamine—pancreatitis	0.000942	0.0149	CcSEcCtD
Afatinib—EGFR—Immune System—IL18—pancreatitis	8.24e-05	0.000105	CbGpPWpGaD
Afatinib—EGFR—Immune System—HGF—pancreatitis	8.21e-05	0.000104	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—NRAS—pancreatitis	8.19e-05	0.000104	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—ALB—pancreatitis	8.16e-05	0.000103	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PTHLH—pancreatitis	8.15e-05	0.000103	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SMO—pancreatitis	8.15e-05	0.000103	CbGpPWpGaD
Afatinib—ABL1—Immune System—CRP—pancreatitis	8.08e-05	0.000102	CbGpPWpGaD
Afatinib—LCK—Disease—PDGFA—pancreatitis	8.07e-05	0.000102	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—XDH—pancreatitis	8.05e-05	0.000102	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—IL6—pancreatitis	8.04e-05	0.000102	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—NRAS—pancreatitis	8.04e-05	0.000102	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—FGB—pancreatitis	7.97e-05	0.000101	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCL5—pancreatitis	7.97e-05	0.000101	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—KRAS—pancreatitis	7.96e-05	0.000101	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR2A—pancreatitis	7.95e-05	0.000101	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—MDM2—pancreatitis	7.95e-05	0.000101	CbGpPWpGaD
Afatinib—LCK—Immune System—IL18—pancreatitis	7.94e-05	0.000101	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—HRAS—pancreatitis	7.93e-05	0.000101	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—MDM2—pancreatitis	7.92e-05	0.0001	CbGpPWpGaD
Afatinib—LCK—Immune System—HGF—pancreatitis	7.91e-05	0.0001	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PTHLH—pancreatitis	7.85e-05	9.96e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SMO—pancreatitis	7.85e-05	9.96e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—LPL—pancreatitis	7.79e-05	9.89e-05	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—HRAS—pancreatitis	7.78e-05	9.86e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PPP3CA—pancreatitis	7.77e-05	9.86e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—TLR4—pancreatitis	7.75e-05	9.83e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-DRB1—pancreatitis	7.74e-05	9.81e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—INS—pancreatitis	7.72e-05	9.79e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—FGB—pancreatitis	7.68e-05	9.75e-05	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—HRAS—pancreatitis	7.64e-05	9.7e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—MDM2—pancreatitis	7.63e-05	9.68e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TGFB1—pancreatitis	7.61e-05	9.66e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—INS—pancreatitis	7.6e-05	9.64e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CCL2—pancreatitis	7.59e-05	9.63e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—IL6—pancreatitis	7.59e-05	9.63e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADH1B—pancreatitis	7.51e-05	9.52e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PPP3CA—pancreatitis	7.49e-05	9.5e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CCL2—pancreatitis	7.48e-05	9.49e-05	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—TGFB1—pancreatitis	7.47e-05	9.47e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SST—pancreatitis	7.45e-05	9.45e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—NRAS—pancreatitis	7.45e-05	9.45e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—LPL—pancreatitis	7.44e-05	9.44e-05	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL6—pancreatitis	7.44e-05	9.44e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—ICAM1—pancreatitis	7.43e-05	9.42e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GCG—pancreatitis	7.41e-05	9.41e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DUSP6—pancreatitis	7.39e-05	9.37e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—SPP1—pancreatitis	7.38e-05	9.36e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—NRAS—pancreatitis	7.34e-05	9.31e-05	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—IL6—pancreatitis	7.32e-05	9.28e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—NRAS—pancreatitis	7.24e-05	9.18e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—MDM2—pancreatitis	7.18e-05	9.11e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SST—pancreatitis	7.18e-05	9.11e-05	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—HRAS—pancreatitis	7.18e-05	9.11e-05	CbGpPWpGaD
Afatinib—LCK—Disease—LPL—pancreatitis	7.17e-05	9.1e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DUSP6—pancreatitis	7.12e-05	9.03e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TNF—pancreatitis	7.11e-05	9.02e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—NRAS—pancreatitis	7.06e-05	8.95e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—KRAS—pancreatitis	7.05e-05	8.95e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR2A—pancreatitis	7.03e-05	8.91e-05	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	7.02e-05	8.91e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—BDKRB2—pancreatitis	7.01e-05	8.89e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—NRAS—pancreatitis	7e-05	8.88e-05	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—KRAS—pancreatitis	6.92e-05	8.78e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CRP—pancreatitis	6.9e-05	8.76e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—NRAS—pancreatitis	6.88e-05	8.73e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CNR1—pancreatitis	6.88e-05	8.72e-05	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—IL6—pancreatitis	6.87e-05	8.72e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—NRAS—pancreatitis	6.78e-05	8.59e-05	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—HRAS—pancreatitis	6.77e-05	8.58e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—BDKRB2—pancreatitis	6.75e-05	8.56e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CRP—pancreatitis	6.65e-05	8.44e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—GCG—pancreatitis	6.64e-05	8.42e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CNR1—pancreatitis	6.63e-05	8.41e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—NRAS—pancreatitis	6.62e-05	8.4e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—TLR4—pancreatitis	6.62e-05	8.4e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-DRB1—pancreatitis	6.61e-05	8.39e-05	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	6.56e-05	8.32e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—LEP—pancreatitis	6.53e-05	8.29e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TGFB1—pancreatitis	6.51e-05	8.25e-05	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	6.51e-05	8.25e-05	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—IL6—pancreatitis	6.48e-05	8.21e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL1B—pancreatitis	6.44e-05	8.17e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—MDM2—pancreatitis	6.42e-05	8.15e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—KRAS—pancreatitis	6.41e-05	8.13e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—GCG—pancreatitis	6.4e-05	8.12e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—TGFB1—pancreatitis	6.39e-05	8.11e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—TLR4—pancreatitis	6.38e-05	8.09e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—KNG1—pancreatitis	6.37e-05	8.08e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-DRB1—pancreatitis	6.37e-05	8.08e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—ICAM1—pancreatitis	6.35e-05	8.05e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—MDM2—pancreatitis	6.33e-05	8.02e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—KRAS—pancreatitis	6.32e-05	8.01e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—TGFB1—pancreatitis	6.3e-05	7.99e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—KRAS—pancreatitis	6.23e-05	7.9e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CCL2—pancreatitis	6.22e-05	7.88e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—NRAS—pancreatitis	6.18e-05	7.84e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—TGFB1—pancreatitis	6.15e-05	7.8e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—KNG1—pancreatitis	6.14e-05	7.79e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—ICAM1—pancreatitis	6.12e-05	7.76e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—KRAS—pancreatitis	6.08e-05	7.71e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TNF—pancreatitis	6.08e-05	7.71e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—KRAS—pancreatitis	6.03e-05	7.64e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CXCL8—pancreatitis	6e-05	7.62e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—HRAS—pancreatitis	6e-05	7.6e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PLA2G1B—pancreatitis	5.99e-05	7.6e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—NRAS—pancreatitis	5.96e-05	7.56e-05	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—NRAS—pancreatitis	5.94e-05	7.53e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—KRAS—pancreatitis	5.92e-05	7.51e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CXCL8—pancreatitis	5.91e-05	7.5e-05	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—HRAS—pancreatitis	5.88e-05	7.46e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PDGFA—pancreatitis	5.86e-05	7.43e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—KRAS—pancreatitis	5.83e-05	7.4e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—LPL—pancreatitis	5.82e-05	7.38e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—A2M—pancreatitis	5.78e-05	7.34e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CASP3—pancreatitis	5.75e-05	7.29e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—IL6—pancreatitis	5.74e-05	7.28e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—NRAS—pancreatitis	5.72e-05	7.26e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—KRAS—pancreatitis	5.7e-05	7.23e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CASP3—pancreatitis	5.66e-05	7.18e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PDGFA—pancreatitis	5.65e-05	7.16e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—MDM2—pancreatitis	5.62e-05	7.13e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—INS—pancreatitis	5.58e-05	7.08e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCL2—pancreatitis	5.49e-05	6.96e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—HRAS—pancreatitis	5.45e-05	6.91e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—NRAS—pancreatitis	5.39e-05	6.83e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—HRAS—pancreatitis	5.37e-05	6.81e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCL5—pancreatitis	5.33e-05	6.76e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—INS—pancreatitis	5.33e-05	6.76e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—KRAS—pancreatitis	5.32e-05	6.75e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—HRAS—pancreatitis	5.29e-05	6.72e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALDH2—pancreatitis	5.29e-05	6.71e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL6—pancreatitis	5.22e-05	6.62e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—LPL—pancreatitis	5.21e-05	6.61e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—HRAS—pancreatitis	5.16e-05	6.55e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL6—pancreatitis	5.14e-05	6.52e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL5—pancreatitis	5.14e-05	6.51e-05	CbGpPWpGaD
Afatinib—LCK—Disease—INS—pancreatitis	5.14e-05	6.51e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—KRAS—pancreatitis	5.13e-05	6.51e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—HRAS—pancreatitis	5.12e-05	6.5e-05	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—KRAS—pancreatitis	5.11e-05	6.48e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—IL6—pancreatitis	5.07e-05	6.43e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL1B—pancreatitis	5.04e-05	6.39e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—HRAS—pancreatitis	5.03e-05	6.38e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—LPL—pancreatitis	5.02e-05	6.37e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—HRAS—pancreatitis	4.96e-05	6.29e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—IL6—pancreatitis	4.94e-05	6.27e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SPP1—pancreatitis	4.94e-05	6.26e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—KRAS—pancreatitis	4.93e-05	6.25e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CXCL8—pancreatitis	4.91e-05	6.23e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—IL6—pancreatitis	4.9e-05	6.22e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—HRAS—pancreatitis	4.84e-05	6.14e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NRAS—pancreatitis	4.82e-05	6.11e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—IL6—pancreatitis	4.82e-05	6.11e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—MDM2—pancreatitis	4.8e-05	6.09e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SPP1—pancreatitis	4.76e-05	6.03e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NRAS—pancreatitis	4.75e-05	6.02e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—IL6—pancreatitis	4.74e-05	6.02e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2A—pancreatitis	4.7e-05	5.96e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—MDM2—pancreatitis	4.64e-05	5.89e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—KRAS—pancreatitis	4.64e-05	5.88e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—MDM2—pancreatitis	4.63e-05	5.87e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2A—pancreatitis	4.53e-05	5.74e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—HRAS—pancreatitis	4.52e-05	5.74e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TGFB1—pancreatitis	4.48e-05	5.68e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—MDM2—pancreatitis	4.43e-05	5.62e-05	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	4.41e-05	5.59e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TGFB1—pancreatitis	4.41e-05	5.59e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—LEP—pancreatitis	4.37e-05	5.54e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—HRAS—pancreatitis	4.36e-05	5.53e-05	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—HRAS—pancreatitis	4.34e-05	5.51e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCL8—pancreatitis	4.34e-05	5.51e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—IL6—pancreatitis	4.33e-05	5.49e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL1B—pancreatitis	4.31e-05	5.46e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—PTGS2—pancreatitis	4.27e-05	5.42e-05	CbGpPWpGaD
Afatinib—LCK—Disease—MDM2—pancreatitis	4.27e-05	5.42e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PPARG—pancreatitis	4.25e-05	5.39e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—NRAS—pancreatitis	4.22e-05	5.35e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—LEP—pancreatitis	4.21e-05	5.34e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—HRAS—pancreatitis	4.19e-05	5.31e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—IL6—pancreatitis	4.17e-05	5.29e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—INS—pancreatitis	4.17e-05	5.28e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CASP3—pancreatitis	4.16e-05	5.27e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL1B—pancreatitis	4.15e-05	5.26e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—KRAS—pancreatitis	4.15e-05	5.26e-05	CbGpPWpGaD
Afatinib—LCK—Disease—PTGS2—pancreatitis	4.12e-05	5.22e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—KRAS—pancreatitis	4.08e-05	5.18e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GCG—pancreatitis	4.01e-05	5.08e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—NRAS—pancreatitis	3.94e-05	5e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HRAS—pancreatitis	3.94e-05	5e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ALB—pancreatitis	3.82e-05	4.85e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL6—pancreatitis	3.77e-05	4.78e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—INS—pancreatitis	3.73e-05	4.73e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCL2—pancreatitis	3.67e-05	4.66e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—KRAS—pancreatitis	3.63e-05	4.6e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—NRAS—pancreatitis	3.6e-05	4.57e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—INS—pancreatitis	3.6e-05	4.56e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL2—pancreatitis	3.54e-05	4.49e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HRAS—pancreatitis	3.52e-05	4.47e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NRAS—pancreatitis	3.48e-05	4.42e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HRAS—pancreatitis	3.47e-05	4.4e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—NRAS—pancreatitis	3.47e-05	4.4e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—KRAS—pancreatitis	3.39e-05	4.3e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL6—pancreatitis	3.37e-05	4.28e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTGS2—pancreatitis	3.34e-05	4.24e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—NRAS—pancreatitis	3.33e-05	4.22e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL6—pancreatitis	3.32e-05	4.21e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TGFB1—pancreatitis	3.24e-05	4.1e-05	CbGpPWpGaD
Afatinib—LCK—Disease—NRAS—pancreatitis	3.2e-05	4.07e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—LPL—pancreatitis	3.15e-05	3.99e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MDM2—pancreatitis	3.1e-05	3.94e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—KRAS—pancreatitis	3.1e-05	3.93e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—TGFB1—pancreatitis	3.09e-05	3.92e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—HRAS—pancreatitis	3.08e-05	3.91e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—KRAS—pancreatitis	3e-05	3.8e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MDM2—pancreatitis	2.99e-05	3.8e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—KRAS—pancreatitis	2.99e-05	3.79e-05	CbGpPWpGaD
Afatinib—LCK—Disease—TGFB1—pancreatitis	2.98e-05	3.78e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL6—pancreatitis	2.95e-05	3.74e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL8—pancreatitis	2.9e-05	3.68e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HRAS—pancreatitis	2.88e-05	3.66e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—KRAS—pancreatitis	2.86e-05	3.63e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL8—pancreatitis	2.8e-05	3.55e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CASP3—pancreatitis	2.78e-05	3.52e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL6—pancreatitis	2.76e-05	3.5e-05	CbGpPWpGaD
Afatinib—LCK—Disease—KRAS—pancreatitis	2.76e-05	3.5e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CASP3—pancreatitis	2.68e-05	3.4e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—HRAS—pancreatitis	2.64e-05	3.34e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HRAS—pancreatitis	2.55e-05	3.23e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—HRAS—pancreatitis	2.54e-05	3.22e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL6—pancreatitis	2.52e-05	3.2e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL6—pancreatitis	2.44e-05	3.09e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—HRAS—pancreatitis	2.43e-05	3.09e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL6—pancreatitis	2.43e-05	3.08e-05	CbGpPWpGaD
Afatinib—LCK—Disease—HRAS—pancreatitis	2.34e-05	2.97e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NRAS—pancreatitis	2.33e-05	2.95e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—IL6—pancreatitis	2.33e-05	2.95e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PPARG—pancreatitis	2.3e-05	2.91e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—INS—pancreatitis	2.25e-05	2.86e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NRAS—pancreatitis	2.24e-05	2.85e-05	CbGpPWpGaD
Afatinib—LCK—Disease—IL6—pancreatitis	2.24e-05	2.85e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TGFB1—pancreatitis	2.16e-05	2.74e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TGFB1—pancreatitis	2.09e-05	2.65e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALB—pancreatitis	2.07e-05	2.62e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—KRAS—pancreatitis	2e-05	2.54e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—KRAS—pancreatitis	1.93e-05	2.45e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTGS2—pancreatitis	1.81e-05	2.29e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HRAS—pancreatitis	1.7e-05	2.16e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HRAS—pancreatitis	1.64e-05	2.08e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6—pancreatitis	1.63e-05	2.07e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6—pancreatitis	1.57e-05	1.99e-05	CbGpPWpGaD
